Skip to content

A clinical study of MK-8527 in people with HIV-1 (MK-8527-004)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-503682-39-00
Acronym
MK-8527-004
Enrollment
5
Registered
2023-06-16
Start date
2023-11-13
Completion date
2024-01-31
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-1 (Human Immunodeficiency Virus Type 1)

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Romania

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026